LSA
TARS icon

Leonteq Securities AG’s Tarsus Pharmaceuticals TARS Stock Holding History

Leonteq Securities AG’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Hold
2,000
– – ﹤0.01% 655
2026
Q1 		$140K Hold
2,000
– – 0.01% 669
2025
Q4 		$164K Sell
2,000
-4,500
-69% -$336K 0.01% 705
2025
Q3 		$386K Buy
+6,500
New +$320K 0.01% 458

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Leonteq Securities AG's TARS Position: Q2 2026 in Review

Leonteq Securities AG held its Tarsus Pharmaceuticals (TARS) position steady in Q2 2026 at 2,000 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #655.

Leonteq Securities AG first reported a position in TARS in Q3 2025 and has held it in 4 quarters since. The position peaked at $386K in Q3 2025. 256 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Leonteq Securities AG held 2,000 shares of Tarsus Pharmaceuticals worth $126K as of Q2 2026.
  • Leonteq Securities AG left its Tarsus Pharmaceuticals share count unchanged in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #655 holding.
  • Leonteq Securities AG first reported a position in Tarsus Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Leonteq Securities AG's Tarsus Pharmaceuticals position peaked at $386K in Q3 2025.
  • 256 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.